HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NARC

This article was originally published in The Rose Sheet

Executive Summary

National Advertising Review Council President and CEO James Guthrie will step down from his position at the end of July, NARC reports April 18, noting it will announce the process for selecting his successor shortly. Guthrie will stay involved in the advertising industry through teaching and related pursuits, agency notes. Under his direction, the advertising industry's self-regulatory body effectively developed new sources of revenue, expanded its staff, launched the Electronic Retailing Self-Regulation Program, produced a white paper for the food industry and "guided critical initiatives to address issues of advertising to children," NARC says...

You may also be interested in...



NARC CEO

Federal Trade Commission Bureau of Consumer Protection Deputy Director Lee Peeler is tapped National Advertising Review Council president and CEO, Council of Better Business Bureaus announces July 24. Effective Sept. 11, Peeler succeeds James Guthrie, who in April announced plans to step down (1"The Rose Sheet" April 24, 2006, In Brief). Peeler, who also will become exec VP, national advertising self-regulation at CBBB, brings experience with a "wide range of advertising law issues," bureau says. He joined FTC in 1973, and during his tenure served for 16 years as associate director of the Bureau of Consumer Protection's Division of Advertising Practices...

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel